Neurobiology of Aging
Volume 28, Issue 8 , Pages 1170-1178 , August 2007

Lipid peroxidation in brain during aging in the senescence-accelerated mouse (SAM)

  • A.L. Petursdottir

      Affiliations

    • Department of Physiology, Faculty of Medicine, University of Iceland, Vatnsmyrarvegi 16, IS-101 Reykjavik, Iceland
    • ,
  • S.A. Farr

      Affiliations

    • Geriatric Research Education and Clinical Center (GRECC), VA Medical Center, St. Louis, MO, USA
    • Department of Internal Medicine, Division of Geriatric Medicine, St. Louis University School of Medicine, St. Louis, MO, USA
    • ,
  • J.E. Morley

      Affiliations

    • Geriatric Research Education and Clinical Center (GRECC), VA Medical Center, St. Louis, MO, USA
    • Department of Internal Medicine, Division of Geriatric Medicine, St. Louis University School of Medicine, St. Louis, MO, USA
    • ,
  • W.A. Banks

      Affiliations

    • Geriatric Research Education and Clinical Center (GRECC), VA Medical Center, St. Louis, MO, USA
    • Department of Internal Medicine, Division of Geriatric Medicine, St. Louis University School of Medicine, St. Louis, MO, USA
    • ,
  • G.V. Skuladottir

      Affiliations

    • Department of Physiology, Faculty of Medicine, University of Iceland, Vatnsmyrarvegi 16, IS-101 Reykjavik, Iceland
    • Corresponding Author InformationCorresponding author. Tel.: +354 525 4825; fax: +354 525 4886.

Received 12 January 2006 ,Revised 18 May 2006 ,Accepted 30 May 2006.

References 

  1. Arivazhagan P, Panneerselvan C. Effect of dl-α-lipoic acid on neural antioxidants in aged rats. Pharmacol Res. 2000;42:219–222
  2. Balu M, Sangeetha P, Haripiya D, Panneerselvam C. Rejuvenation of antioxidant system in central nervous system of aged rats by grape seed extract. Neurosci Lett. 2005;383:295–300
  3. Bourre JM, Dumont O, Durand G. Brain phospholipids as dietary source of (n-3) polyunsaturated fatty acids for nervous tissue in the rat. J Neurochem. 1993;60:2018–2028
  4. Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med. 2001;7:548–554
  5. Butterfield DA. Amyloid beta-peptide (1–42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res. 2002;36:1307–1313
  6. Carrié I, Clément M, de Javel D, Francés H, Bourre J-M. Specific phospholipid fatty acid composition of brain regions in mice: effects of n-3 polyunsaturated fatty acid deficiency and phospholipid supplementation. J Lipid Res. 2000;41:465–472
  7. Carrié I, Clément M, de Javel D, Francés H, Bourre J-M. Phospholipid supplementation reverses behavioural and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in mice. J Lipid Res. 2000;41:473–480
  8. Craft NE, Haitema TB, Garnett KM, Fitch KA, Dorey CK. Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J Nutr Health Aging. 2004;8:156–162
  9. Delion S, Chalon S, Guilloteau D, Lejeune B, Besnard J-C, Durand G. Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or a n-3 polyunsaturated fatty acid-deficient diet. J Lipid Res. 1997;38:680–689
  10. Drake J, Link CD, Butterfield DA. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1–42) in a transgenic Caenorhabditis elegans model. Neurobiol Aging. 2003;24:415–420
  11. Farr SA, Poon HF, Dogrukol-Ak D, Drake J, Banks WA, Eyerman E, et al. The antioxidants α-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem. 2003;84:1173–1183
  12. Favreliére S, Stadelmann-Ingrand S, Huguet F, de Javel D, Piriou A, Tallineu C, et al. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol Aging. 2000;21:653–660
  13. Flood JF, Morley JE. Early onset of age-related impairment of aversive and appetitive learning in the SAM-P/8 mouse. J Gerontol. 1992;47:B52–B59
  14. Flood JF, Morley JE, Roberts E. An amyloid β-protein fragment, Aβ[12–28], equipotently impairs post-training memory processing when injected into different limbic system structures. Brain Res. 1994;663:271–276
  15. Folch J, Lees M, Sloane Stanley G. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:495–509
  16. Gsell W, Conrad R, Hickethier M, Sofic E, Frölich L, Wichart I, et al. Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J Neurochem. 1995;64:1216–1223
  17. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992;59:1609–1623
  18. Halliwell B. Oxygen radicals as key mediators in neurological disease: fact or fiction?. Ann Neurol. 1992;32(Suppl):S10–S15
  19. Hutton M, Perez-Tur J, Hardy J. Genetics of Alzheimer's disease. Essays Biochem. 1998;33:117–131
  20. Ikezu T, Luo X, Weber GA, Zhao J, McCabe L, Buescher JL, et al. Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity. J Neurochem. 2003;85:925–934
  21. Jurgens G, Fell A, Ledinski G, Chen Q, Paltauf F. Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline and ethanolamine plasmalogens. Chem Phys Lipids. 1995;77:25–31
  22. Kalmijn S. Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies. J Nutr Health Aging. 2000;4:202–207
  23. Kanski J, Aksenova M, Schöneich C, Butterfield DA. Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer's amyloid β-peptide (1–42). Free Radic Biol Med. 2002;32:1205–1211
  24. Karelson E, Bogdanovic N, Garlind A, Winblad B, Zilmer K, Kullisaar T, et al. The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defence. Neurochem Res. 2001;26:353–361
  25. Kato K, Kurobe N, Suzuki F, Morishita R, Asano T, Sato T, et al. Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease. J Mol Neurosci. 1991;3:95–99
  26. Kish SJ, Morito CL, Hornykiewicz O. Brain glutathione peroxidase in neurodegenerative disorders. Neurochem Pathol. 1986;4:23–28
  27. Kolosova NG, Shcheglova TV, Sergeeva SV, Loskutova LV. Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats. Neurobiol Aging. 2006;27:1289–1297
  28. Kumar VB, Farr SA, Flood JF, Kamlesh V, Franco M, Banks WA, et al. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides. 2000;21:1769–1775
  29. Lovell MA, Ehmann WD, Butler SM, Markesbery WR. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurol. 1995;45:1594–1601
  30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265–275
  31. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, et al. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol. 1998;150:40–44
  32. Markesbery WR, Lovell MA. Four-hydroxynonenal, a product of lipid peroxidation is increased in the brain in Alzheimer's disease. Neurobiol Aging. 1998;19:33–36
  33. Markesbery WR, Kryscio RJ, Lovell MA, Morrow JD. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol. 2005;58:730–735
  34. Montine TJ, Montine KS, McMahan W, Markesbery WR, Quinn JF, Morrow JD. F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxid Redox Signal. 2005;7:269–275
  35. Morley JE, Farr SA, Kumar VB, Banks WA. Alzheimer's disease through the eye of a mouse, acceptance lecture for the 2001 Gayle A Olson and Richard D Olson Prize. Peptides. 2002;23:589–599
  36. Morley JE, Farr SA, Flood JE. Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice. Neurobiol Learn Membr. 2002;78:125–138
  37. Nourooz-Zadeh J, Liu EHC, Yhlen B, Anggård EE, Halliwell B. F4-Isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. J Neurochem. 1999;72:734–740
  38. Olney JW. New insights and new issues in developmental neurotoxicology. Neurotoxicol. 2002;23:659–668
  39. Poon HF, Joshi G, Sultana R, Farr SA, Banks WA, Morley JE, et al. Antisense directed at the Aβ region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res. 2004;1018:86–96
  40. Poon HF, Farr SA, Thongboonkerd V, Lynn BC, Banks WA, Morley JE, et al. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem Intern. 2005;46:159–168
  41. Porter NA, Caldwell SE, Mills KA. Mechanisms of free radical oxidation of unsaturated lipids. Lipids. 1995;30:277–290
  42. Prasad MR, Lovell MA, Yatin M, Dhillon H, Markesbery WR. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res. 1998;23:81–88
  43. Richardson JS. Free radicals in the genesis of Alzheimer's disease. Ann NY Acad Sci. 1993;695:73–76
  44. Schuessel K, Leutner S, Cairns NJ, Muller WE, Eckert A. Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain. J Neural Transmembr. 2004;111:1167–1182
  45. Soderberg M, Edlund C, Kristensson K, Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids. 1991;26:421–425
  46. Su Q, Rowley KG, ÓDea K. Stability of individual carotenoids, retinol and tocopherols in human plasma during exposure to light and after extraction. J Chromatogr B. 1999;729:191–198
  47. Takeda T, Hosokawa M, Takeshita S, Irino M, Higuchi K, Matsushita T, et al. A new murine model of accelerated senescence. Mech Aging Dev. 1981;17:183–194
  48. Ulmann L, Mimouni V, Roux S, Porsolt R, Posson J-P. Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats. Prostagl Leukotr Essent Fatty Acids. 2001;64:189–195
  49. Varadarajan S, Yatin S, Aksenova M, Butterfield DA. Review: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol. 2000;130:184–208
  50. Williams TI, Lynn BC, Markesbery WR, Lovell MA. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging. 2006;27:1094–1099
  51. Yagi H, Katoh S, Akiguchi I, Takeda T. Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in resent memory. Brain Res. 1988;474:86–93
  52. Yasui F, Ishibashi M, Matsugo S, Kojo S, Oomura Y, Sasaki K. Brain lipid hydroperoxide level increases in senescence-accelerated mice at an early age. Neurosci Lett. 2003;350:66–68
  53. Yatin SM, Varadarajan S, Link CD, Butterfield DA. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1–42). Neurobiol Aging. 1999;20:325–330
  54. Zhang Y, Appelkvist E-L, Kristensson K, Dallner G. The lipid compositions of different regions of rat brain during development and aging. Neurobiol Aging. 1996;17:869–875
  55. Zoeller RA, Morand OH, Raetz CRH. A possible role for plasmalogens in protecting animal cells against photosensitized killing. J Biol Chem. 1988;263:11590–11596

PII: S0197-4580(06)00191-6

doi: 10.1016/j.neurobiolaging.2006.05.033

Neurobiology of Aging
Volume 28, Issue 8 , Pages 1170-1178 , August 2007

Article Tools

* Image Usage & Resolution